Table 4 Scenario analysis results for RZV versus no HZ vaccine for selected Canadian adult IC populations
| Â | Median (90% UI) | ||
|---|---|---|---|
ICER, $ per QALY gained | NNV to avoid | ||
1 HZ case | 1 PHN case | ||
Breast cancer scenario | 24,328 (15,010–39,864) | 6 (4–9) | 23 (16–37) |
Renal transplant scenario | 27,237 (8631–58,779) | 6 (4–9) | 42 (27–71) |
HIV scenario | 67,207 (39,698–115,403) | 7 (5–11) | 56 (36–92) |
Hodgkin lymphoma scenario | 81,470 (38,262–179,274) | 7 (4–17) | 38 (19–88) |